IBMP produces the amplification module of the HIV/HCV/HBV NAT Kit, among other molecular tests, assuring the safety of the Brazilian blood donation network. Differential molecular diagnosis of zika, dengue and chikungunya viruses is currently at the implementation phase.
Generating knowledge and biotech products in the healthcare field requires intensive and cooperative effort - IBMP works in partnership with Tecpar, Fiocruz, national universities and international organizations, including the CDC and the FDA.
IBMP is involved in the epidemiological surveillance of SUS (the Brazilian Unified National Health System), by developing molecular diagnostics solutions. With a total area of 2,200 m² and a modern production facility, the Institute operates under Good Manufacturing Practices since 2011.
Benchmark in molecular diagnostics, IBMP heads scientific projects that bring together expertise in Biotechnology and Nanotechnology to devise novel solutions in diagnostics for SUS (Brazilian Unified National Health System).
The development of products for healthcare and diagnostics requires expertise in the area and the use of cutting edge technology. The ongoing projects at IBMP employ the latest technology platforms.